文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

支气管镜对经皮气管切开安全性的影响:一项随机对照试验

The impact of bronchoscopy on the safety of percutaneous tracheostomy: a randomized controlled trial.
PubMed 文献 · Crit Care · 2026-03-18
一句话结论在经验丰富的操作者中,经皮扩张气管切开不加支气管镜不增加主要并发症或死亡率,且手术时间更短。

该前瞻性随机对照试验纳入307例需经皮扩张气管切开的机械通气成人,比较支气管镜引导与非支气管镜引导两种方式。主要终点为24小时手术相关并发症复合终点,支气管镜组轻微并发症(尤其术中高血压)更多(37.6% vs 22.7%,P=0.005),主要并发症率相同(5.2%,P=0.8)。两组24小时死亡率(均1%)、30天死亡率(24.8% vs 26.6%,P=0.72)和住院时间(40.5±48.7天 vs 38.9±33.1天,P=0.73)无显著差异,但支气管镜组手术时间更长(5.46 vs 4.17分钟,P=0.003)。作者认为,对经验丰富的操作者,不加支气管镜的经皮扩张气管切开是安全的,可能更高效。

要点

  • 支气管镜组与非支气管镜组主要并发症率相同(5.2%,P=0.8),24小时死亡率均1%。
  • 支气管镜组轻微并发症更多(37.6% vs 22.7%,P=0.005),尤其术中高血压。
  • 支气管镜组手术时间更长(5.46 vs 4.17分钟,P=0.003)。
  • 两组30天死亡率(24.8% vs 26.6%,P=0.72)和住院时间(40.5±48.7天 vs 38.9±33.1天,P=0.73)无显著差异。
  • 作者认为,对经验丰富的操作者,不加支气管镜的经皮扩张气管切开是安全的,可能更高效;需多中心研究评估普适性。

适用人群与场景

  • 需要经皮扩张气管切开的机械通气成人患者。

研究设计与关键结果

  • 前瞻性随机对照试验,纳入307例成人,随机分为支气管镜组(n=154)和非支气管镜组(n=153)。
  • 主要终点24小时手术相关并发症复合终点:主要并发症率两组相同(5.2%,P=0.8);轻微并发症支气管镜组37.6% vs 非支气管镜组22.7%(P=0.005),尤其术中高血压更常见。
  • 24小时死亡率两组均1%;30天死亡率支气管镜组24.8% vs 非支气管镜组26.6%(P=0.72);住院时间支气管镜组40.5±48.7天 vs 非支气管镜组38.9±33.1天(P=0.73)。
  • 平均手术时间支气管镜组5.46分钟 vs 非支气管镜组4.17分钟(P=0.003)。

证据类型、等级与局限

  • 证据类型:前瞻性随机对照试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对经验丰富的操作者,经皮扩张气管切开不加支气管镜不增加主要并发症或死亡率,且手术时间更短。
  • 支气管镜引导可能增加轻微并发症(尤其术中高血压)和手术时间。
  • 作者认为,对经验丰富的操作者,不加支气管镜的经皮扩张气管切开是安全的,可能更高效;需多中心研究评估普适性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Bronchoscopic guidance is commonly used during percutaneous dilational tracheostomy (PCT) despite limited and conflicting evidence; this study aimed to evaluate whether bronchoscopy improves the safety of PCT in mechanically ventilated patients. METHODS: This prospective, randomized controlled study compared two approaches of percutaneous tracheostomy; with and without bronchoscopy assistance. The primary outcome measured was a composite of procedure-related complications at 24 hours, classified as minor (e.g., bleeding, desaturation) or major (e.g., airway loss, tracheal rupture, severe pneumothorax, major bleeding requiring transfusion and death). Secondary outcomes included procedure duration, 30-day mortality, and hospital length of stay. INTERVENTIONS: PCT performed with or without bronchoscopic guidance. RESULTS: 307 adults requiring PCT between 2016 and 2024 were randomized to PCT with bronchoscopy (n=154) or without (n=153). Minor complications, particularly intra - procedural hypertension, were more frequent in the bronchoscopy group versus the non bronchoscopy (37.6% vs. 22.7% respectively p = 0.005). No significant differences were found in 24-hour mortality (1% for both), 30-day mortality (24.8% vs. 26.6%; p = 0.72), or hospital length of stay (40.5 ± 48.7 days vs. 38.9 ± 33.1 days; p = 0.73). Mean procedure duration was longer with bronchoscopy (5.46 vs. 4.17 minutes; p = 0.003). Major complication rates were identical (5.2% p = 0.8). CONCLUSIONS: Bronchoscopy during PCT does not reduce major complications or mortality, but increases procedure time, complexity, and costs. For experienced proceduralists, PCT without bronchoscopy is safe and may represent a more efficient approach. Multicenter studies are needed to assess generalizability of these findings. TRIAL REGISTRATION: This study was registered at ClinicalTrials.gov (identifier: NCT02802527) on April 13 2016.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Nachshon A, Shapiro A, Goldfarb S, et al. The impact of bronchoscopy on the safety of percutaneous tracheostomy: a randomized controlled trial. Crit Care. 2026. PMID: 41851791. doi:10.1186/s13054-026-05912-2

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。